Amarin Raises $70 Million PIPE

Amarin Corp. (Nasdaq: AMRN), an Ireland-based developer of cardiovascular and CNS drugs, has agreed to raise $70 million in PIPE financing. raise up to $60 million in PIPE funding. New backers include Abingworth Management led the new investors, which also included APG Asset Management, Great Point Partners, RA Capital and Tavistock Life Sciences. Return backers -- who participated in a PIPE last year -- include Fountain Healthcare Partners, Longitude Capital, Sofinnova Ventures and OrbiMed Advisors.

North AmericaUSBriefs